Evidence map›Paper›PMID 42878204›Full record

ReviewClinical pharmacology and therapeutics2026

Advancing Pregnancy and Pediatric Science through the NIH Transporter Elucidation Network.

Joanne Wang, Jashvant D Unadkat, Samuel Lm Arnold, John K Fallon, Pouria Fattahi, Dan Dongeun Huh, Nicholas Ieronimakis, Edward J Kelly, Svetlana Lutsenko, Robert M Stroud and 7 more

Abstract readReview
In one paragraph

Review in Clinical pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Joanne WangDepartment of Pharmaceutics, School of Pharmacy University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-6641-9101
Jashvant D UnadkatDepartment of Pharmaceutics, School of Pharmacy University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-4820-8455
Samuel Lm ArnoldDepartment of Pharmaceutics, School of Pharmacy University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-8290-2347
John K FallonDivision of Pharmacoengineering and Molecular Pharmaceutics, and Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0003-1848-0121
Pouria FattahiDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-0812-5882
Dan Dongeun HuhDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-5718-6884
Nicholas IeronimakisDivision of Clinical Investigation, Madigan Army Medical Center, Tacoma, Washington, USA.ORCID https://orcid.org/0000-0002-7078-8230
Edward J KellyDepartment of Pharmaceutics, School of Pharmacy University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-6534-9313
Svetlana LutsenkoDepartment of Physiology, Pharmacology and Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-5275-2587
Robert M StroudDepartment of Biochemistry and Biophysics, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-2083-5665
Jacqueline B TileyDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-9977-1184
Jia YangDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-3992-4070
Xujia ZhouDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-2491-0933
Hao ZhuCenter for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, Louisiana, USA.ORCID https://orcid.org/0000-0002-3559-6129
Rajini RaoDepartment of Physiology, Pharmacology and Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-1833-5971
Kathleen M GiacominiDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-8041-5430
Lauren M AleksunesDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.ORCID https://orcid.org/0000-0002-0032-1037

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human gestation is characterized by dynamic changes in maternal physiology and maturation of tissue functions before and after birth. The fetus and neonate are highly dependent upon transfer of maternal nutrients via the placenta and lactating mammary gland, which frequently involve selective membrane transporter proteins. At the same time, developmental changes in fetal and infant transport mechanisms critical for regulating absorption at the intestinal and blood-brain barriers are occurring. Coordinate regulation of cellular entry and efflux of nutrients, supplements, and xenobiotics, including drugs and environmental chemicals, must occur during this critical developmental period. In 2023, the National Institutes of Health launched the Transporter Elucidation Network (TEN) across four centers. This initiative applies experimental, computational, and translational approaches to (1) identify SoLute Carrier (SLC) superfamily and ATP-binding cassette (ABC) transporters in the human placenta, mammary gland, as well as the pediatric brain and intestinal barriers and, (2) characterize their localization, expression, function, and regulation. The Network seeks to identify functional determinants of transporters as gatekeepers of entry to placenta, mammary gland and brain, and applies structural biology, proteomics, metabolomics, organoids, liquid biopsies, and microphysiological systems to this end. Computational strategies, such as machine learning, virtual screening, physiologically based pharmacokinetics, and perinatal epidemiology complement our experimental approaches. This paper highlights the TEN's multidisciplinary strategies to address current challenges in perinatal and pediatric transporter research and its commitment to advancing state-of-the-art tools and new approach methodologies to fill critical gaps in our understanding of nutrient and xenobiotic exposure during early human development.

Identifiers

PMID42878204
PMCPMC13670881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.